These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 2495152

  • 1. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
    Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM.
    Brain Res; 1989 Jan 16; 477(1-2):90-9. PubMed ID: 2495152
    [Abstract] [Full Text] [Related]

  • 2. Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.
    Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM.
    Prog Clin Biol Res; 1989 Jan 16; 317():837-48. PubMed ID: 2557644
    [Abstract] [Full Text] [Related]

  • 3. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC.
    Lab Invest; 1989 Mar 16; 60(3):375-89. PubMed ID: 2494388
    [Abstract] [Full Text] [Related]

  • 4. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
    Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM.
    Acta Neuropathol; 1987 Mar 16; 74(1):39-46. PubMed ID: 2444063
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.
    J Neural Transm Suppl; 1998 Mar 16; 53():169-80. PubMed ID: 9700655
    [Abstract] [Full Text] [Related]

  • 6. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.
    Brion JP, Hanger DP, Bruce MT, Couck AM, Flament-Durand J, Anderton BH.
    Biochem J; 1991 Jan 01; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.
    Bondareff W, Wischik CM, Novak M, Amos WB, Klug A, Roth M.
    Am J Pathol; 1990 Sep 01; 137(3):711-23. PubMed ID: 2169192
    [Abstract] [Full Text] [Related]

  • 8. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease.
    Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM.
    Brain Res; 1991 Jan 18; 539(1):11-8. PubMed ID: 1849776
    [Abstract] [Full Text] [Related]

  • 9. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K, Grundke-Iqbal I.
    Mol Neurobiol; 1991 Jan 18; 5(2-4):399-410. PubMed ID: 1726645
    [Abstract] [Full Text] [Related]

  • 10. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Nukina N, Kosik KS, Selkoe DJ.
    Proc Natl Acad Sci U S A; 1987 May 18; 84(10):3415-9. PubMed ID: 3106969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC, Schneider A, Mandelkow EM, Hyman BT.
    Acta Neuropathol; 2002 Jan 18; 103(1):26-35. PubMed ID: 11837744
    [Abstract] [Full Text] [Related]

  • 13. The reinterpretation of the immunochemical study of Alzheimer neurofibrillary tangles.
    Nukina N.
    Ann Med; 1989 Jan 18; 21(2):117-9. PubMed ID: 2475148
    [Abstract] [Full Text] [Related]

  • 14. Protein TAU variants present in paired helical filaments (PHFs) of Alzheimer brains.
    Gache Y, Ricolfi F, Guilleminot J, Theiss G, Nunez J.
    FEBS Lett; 1990 Oct 15; 272(1-2):65-8. PubMed ID: 2121538
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
    Luna-Muñoz J, García-Sierra F, Falcón V, Menéndez I, Chávez-Macías L, Mena R.
    J Alzheimers Dis; 2005 Sep 15; 8(1):29-41. PubMed ID: 16155347
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Shankar SK, Yanagihara R, Garruto RM, Grundke-Iqbal I, Kosik KS, Gajdusek DC.
    Ann Neurol; 1989 Feb 15; 25(2):146-51. PubMed ID: 2493213
    [Abstract] [Full Text] [Related]

  • 18. Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology.
    Ksiezak-Reding H, Morgan K, Dickson DW.
    Brain Res; 1994 Jun 27; 649(1-2):185-96. PubMed ID: 7953631
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
    Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I.
    Mol Neurobiol; 1994 Jun 27; 9(1-3):119-23. PubMed ID: 7888088
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ.
    Am J Pathol; 2003 Aug 27; 163(2):591-607. PubMed ID: 12875979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.